ND
Natalie Dales
DELAYED 1 MONTH
Chief of Research Operations and Portfolio Strategy
Odyssey Therapeutics, Inc.
Filings
1
Companies
1
Latest
May 7, 2026
Transactions
Signal
Ticker / Company
Insider
Transaction
Value
Filed
No transactions to show.
Natalie Dales
Chief of Research Operations and Portfolio Strategy
Filings
1
Companies
1
Latest
May 7, 2026
Transactions
Signal
Ticker / Company
Insider
Transaction
Value
Filed
No transactions to show.